Authors: Rozenbaum, W Katlama, C Massip, P Bentata, M Zucman, D Delfraissy, JF Trepo, C David, F Lanier, ER Vavro, C Mamet, JP

Citation: W. Rozenbaum et al., Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment, ANTIVIR TH, 6(2), 2001, pp. 135-142

Authors: Lanier, ER Sturge, G McClernon, D Brown, S Halman, M Sacktor, N McArthur, J Atkinson, JH Clifford, D Price, RW Simpson, D Torres, G Catalan, J Marder, K Power, C Hall, C Romero, C Brew, B

Citation: Er. Lanier et al., HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir, AIDS, 15(6), 2001, pp. 747-751

Authors: Limoges, J Poluektova, L Ratanasuwan, W Rasmussen, J Zelivyanskaya, M McClernon, DR Lanier, ER Gendelman, HE Persidsky, Y

Citation: J. Limoges et al., The efficacy of potent anti-retroviral drug combinations tested in a murine model of HIV-1 encephalitis, VIROLOGY, 281(1), 2001, pp. 21-34

Authors: Limoges, J Persidsky, Y Poluektova, L Rasmussen, J Ratanasuwan, W Zelivyanskaya, M McClernon, DR Lanier, ER Gendelman, HE

Citation: J. Limoges et al., Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice, NEUROLOGY, 54(2), 2000, pp. 379-389

Authors: Letendre, SL Lanier, ER McCutchan, JA

Citation: Sl. Letendre et al., Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1, J INFEC DIS, 180(2), 1999, pp. 310-319